[1]
R. R. Gilibili, R. K. Bhamidipati, R. Mullangi, and N. R. Srinivas, “Retrospective and Prospective Human Intravenous and Oral Pharmacokinetic Projection of Dipeptidyl peptidase-IV Inhibitors Using Simple Allometric Principles – Case Studies of ABT-279, ABT-341, Alogliptin, Carmegliptin, Sitagliptin and Vildagliptin”, J Pharm Pharm Sci, vol. 18, no. 3, pp. 434–447, Sep. 2015.